Creatinine is the Best Molecule to Target Adequacy of Peritoneal Dialysis

Laird N.M. , Berkey C.S. , Lowrie E.G. Modelling success or failure of dialysis therapy: The National Cooperative Dialysis Study. Kidney Int 1983; 23(Suppl 13): S101–6.

Boen S. , Haagsma–Schouter W. , Birnie R. Long-term peritoneal dialysis and peritoneal dialysis index. Nephrol Dial Transplant 1978; 7: 377–8.

Churchill D.N. , Taylor D.W. , Keshaviah P.R. , and the CANUSA Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 1996; 7: 198–207.

Maiorca R. , Brunori G. , Zubani R. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients: A longitudinal study. Nephrol Dial Transplant 1995; 10: 2295–305.

Genestier S. , Hedelin G. , Schaffer P. , Faller B. Prognostic factors in CAPD patients: A retrospective study of a 10 year period. Nephrol Dial Transplant 1995; 10: 1905–11.

Selgas R. , Bajo M.A. , Fernandez–Reyes M.J. , Bosque E. , Lopez–Revuelta K. , Jimenez C. An analysis of adequacy of dialysis in a selected population on CAPD for over 3 years: The influence of urea and creatinine kinetics. Nephrol Dial Transplant 1993; 8: 1244–53.

National Kidney Foundation Dialysis Outcomes Quality Initiative. Clinical practice guidelines for perito-neal dialysis adequacy. Am J Kidney Dis 1997; 30(Suppl 2): S67–136.

Blake P. , Bargman J. , Bick J. , Cartier P. , Dasgupta M. , Fine A. Guidelines for adequacy and nutrition in peritoneal dialysis. J Am Soc Nephrol 1999; 6(Suppl 13): S311–21.

Chen H.H. , Shetty A. , Afthentopoulos I.E. , Oreopoulos D.G. Discrepancy between weekly Kt/V and weekly creatinine clearance in patients on CAPD. In: Khanna R. , ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications, 1995; 11: 83–7.

Twardowski Z.J. , Nolph K.D. , Khanna R. Peritoneal equilibration test. In: Khanna R. , Nolph K.D. , Prowant B.F. , Twardowski Z.J. , Oreopoulos D.G. , eds. Advances in CAPD. Toronto: Peritoneal Dialysis Bulletin, 1987; 3: 138–47.

Blake P.G. , Burkart J. , Churchill D. , Daugirdas J. , Depner T. , Hamburger R.J. Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int 1996; 16: 448–56.

Nolph K.D. , Twardowski Z.J. , Keshaviah P.K. Weekly clearance of urea and creatinine on CAPD and NIPD. Perit Dial Int 1992; 12: 298–303.

Tzamaloukas A.H. , Malhotra D. , Murata G.H. Indicators of body size in peritoneal dialysis: Their relation to urea and creatinine clearances. Perit Dial Int 1998; 18: 366–70.

Marx M.A. , Shuler C.L. , Tattersall J.E. , Golper T.A. Plasma iohexol clearance as an alternative to creatinine clearance for CAPD adequacy studies. Kidney Int 1995; 48: 1994–7.

Blake P.G. Critique of CANUSA. Perit Dial Int 1996; 16: 243–5.

Brandes J.C. , Piering W.F. , Beres J.A. , Blumenthal S.S. , Fritsche C. Clinical outcome of CAPD predicted by urea and creatinine kinetics. J Am Soc Nephrol 1992; 2: 1430–5.

Oreopoulos D.G. The optimization of continuous ambulatory peritoneal dialysis. Kidney Int 1999; 55: 1131–49.

Chertow G.M. , Owen W.F. , Lazarus J.M. , Lew N.L. , Lowrie E.G. Exploring the reverse J-shaped curve between urea reduction ratio and mortality. Kidney Int 1999; 56: 1872–80.

Fried L. , Bernadini J. , Piraino B. Neither size nor weight predicts survival in peritoneal dialysis patients. Perit Dial Int 1996; 16: 357–61.

Lowrie E.G. Conceptual model for a core pathobiology of uremia with special reference to anemia, malnourishment and mortality among dialysis patients. Semin Dial 1997; 10: 115–29.

Churchill D.N. , Thorpe K.E. , Nolph K.D. , Keshaviah P.R. , Oreopoulos D.G. , Page D. , for the Canada–U.S.A. (CANUSA) Peritoneal Dialysis Study Group. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J Am Soc Nephrol 1998; 9: 1285–92.

Davies S.J. , Phillips L. , Russell G.I. Peritoneal solute transport predicts survival on CAPD independently of residual renal function. Nephrol Dial Transplant 1998; 13: 962–8.